
AI is already running in clinical trials at Gilead, Roche, IQVIA, and Medidata. This course shows you exactly how — and how to use it yourself.
Built for clinical research professionals who want practical skills, not theory. Every tool, technique, and example in this course is verified, referenced, and in production use today.
In this course you will:
Master AI prompt engineering for clinical trial protocol design and pharmacovigilance
Understand real FDA-EMA 2026 regulatory requirements for AI in drug development
Build AI agent workflows for monitoring, safety surveillance, and TMF management
Automate repetitive clinical operations tasks using free no-code tools
Apply synthetic control arm methodology backed by peer-reviewed evidence
Complete a hands-on capstone project with three real clinical research scenarios
Execute a 90-day personal roadmap with trackers, templates, and documentation tools
No coding. No prior AI experience. Immediately applicable from day one.
Protocol amendments are increasing across every trial phase. Tufts CSDD confirmed it in 2024. AI is the structural solution — and it is already deployed.
This section shows you exactly how Gilead, Medidata, Lokavant, and Tempus are using AI in protocol design right now, with named tools, verified data, and regulatory context you can apply immediately.
In this section you will:
Understand why protocol complexity has nearly doubled since 2010 using Tufts CSDD benchmark data
Apply AI to eligibility criteria optimization, literature synthesis, and patient burden assessment
Evaluate synthetic control arms using FDA-accepted methodology and peer-reviewed 2025 evidence
Use four practical prompt templates for protocol benchmarking you can run this week
Identify which AI feasibility platforms are in production — Medidata, Lokavant, Tempus, IQVIA
Apply the FDA-EMA January 2026 joint AI principles to your protocol submissions today
Real companies. Real tools. Real regulatory requirements.
Pharmacovigilance teams are drowning in case volume. AI is reducing processing time by 70% at major pharma companies right now. Here is exactly how.
This section covers the most rapidly deployed area of AI in clinical research — adverse event processing, signal detection, and risk-based monitoring — with named platforms, peer-reviewed evidence, and the regulatory framework that governs all of it.
In this section you will:
Understand how AI reduces adverse event case processing time using documented real-world deployments
Build a GCP-compliant safety narrative prompt library using ICH E2A structured templates
Evaluate named PV AI platforms including IQVIA Vigilance Detect, Oracle Argus, and Tech Mahindra
Apply machine learning signal detection principles that outperform traditional disproportionality analysis
Assess your workflows against FDA-EMA 2026 joint principles and EU AI Act August 2026 requirements
Design an AI-assisted pharmacovigilance workflow with compliant human oversight built in
Verified data. Named deployments. Immediately applicable.
IQVIA has AI agents running in clinical trials right now. Salesforce Agentforce went live in October 2025. Takeda is already using it. This section shows you how to catch up.
This section connects everything from Topics 1 and 2 to your personal skills and daily workflow — from advanced prompting through autonomous agents to no-code system integration you can build this week without IT involvement.
In this section you will:
Master chain-of-thought, role assignment, and few-shot prompting techniques for clinical research tasks
Understand how AI agents work in clinical trial monitoring, TMF management, and PV surveillance
Identify verified agent deployments at IQVIA, Salesforce, Takeda, and Tech Mahindra with 2025 evidence
Build a no-code workflow automation using Make or Zapier connecting your existing clinical systems
Apply a 90-day personal roadmap with monthly milestones, prompt trackers, and compliance documentation
Evaluate digital twins and living protocols against the current 2026 regulatory landscape
No coding. No budget. Start today.
You have covered three topics, 36 slides, and 44 verified references. This section pulls everything together into five actions you take this week.
The summary chapter consolidates the key evidence, named deployments, and regulatory requirements from all three topics — and closes with a clear, specific action plan so the learning does not stop when the course ends.
In this section you will:
Consolidate the core evidence from Topics 1, 2, and 3 into a single referenced summary
Review the most important named company deployments covered across the full course
Confirm your understanding of the FDA-EMA 2026 joint principles and EU AI Act August 2026 deadline
Identify your five immediate actions — one for each working day of next week
Connect your course learning directly to your 90-day roadmap starting point
Download your complete reference list, capstone project, and personal roadmap PDFs
Everything you need. Nothing you do not. Go apply it.
re you working in clinical research and watching AI transform the industry around you — but not yet in your workflow?
This course closes that gap. In 60 focused minutes you will learn exactly how leading pharmaceutical companies, CROs, and regulatory bodies are deploying AI in clinical trials right now — and walk away with tools, templates, and a 90-day action plan you can apply immediately.
No coding. No data science background. No theory without application.
What you will learn:
Apply AI to clinical trial protocol design using real methods from Gilead, Medidata, and Tufts CSDD benchmark data
Automate adverse event case processing and pharmacovigilance signal detection — reduce manual workload using verified real-world deployments
Build a personal prompt library with role-specific templates for CRAs, PV scientists, regulatory affairs, and data managers
Understand and apply the FDA-EMA January 2026 joint AI principles and EU AI Act requirements to your clinical research submissions
Design AI agent workflows for monitoring, TMF management, and safety surveillance using free and low-cost tools
Evaluate synthetic control arms, RBQM platforms, and AI feasibility tools backed by 44 peer-reviewed and regulatory references
Complete a hands-on capstone project across three real clinical research scenarios with full grading criteria
Execute your personal 90-day AI roadmap with monthly milestones, prompt trackers, and a compliance-ready documentation log
This course is for clinical research associates, pharmacovigilance scientists, regulatory affairs managers, data managers, and clinical project managers at sponsors, CROs, and biotech companies who want practical AI skills — not buzzwords.
What is included: full lecture with 30 quiz questions, presenter scripts, 44 verified references, capstone project, and a downloadable 90-day personal roadmap.
Every tool, every technique, every example is in production use today.